CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
1.380
+0.050 (3.76%)
Nov 7, 2025, 4:00 PM EST - Market closed

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals had revenue of $4.18M in the quarter ending June 30, 2025, with 4.93% growth. This brings the company's revenue in the last twelve months to $31.56M, up 36.64% year-over-year. In the year 2024, CASI Pharmaceuticals had annual revenue of $28.54M, down -15.77%.

Revenue (ttm)
$31.56M
Revenue Growth
+36.64%
P/S Ratio
0.72
Revenue / Employee
$135,468
Employees
233
Market Cap
21.38M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.54M-5.34M-15.77%
Dec 31, 202333.88M-9.23M-21.41%
Dec 31, 202243.11M12.94M42.89%
Dec 31, 202130.17M15.03M99.25%
Dec 31, 202015.14M11.01M266.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro